CH622512A5 - - Google Patents

Download PDF

Info

Publication number
CH622512A5
CH622512A5 CH870277A CH870277A CH622512A5 CH 622512 A5 CH622512 A5 CH 622512A5 CH 870277 A CH870277 A CH 870277A CH 870277 A CH870277 A CH 870277A CH 622512 A5 CH622512 A5 CH 622512A5
Authority
CH
Switzerland
Prior art keywords
uracil
tolyloxyuracil
chem
describes
substituted
Prior art date
Application number
CH870277A
Other languages
English (en)
French (fr)
Inventor
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CH622512A5 publication Critical patent/CH622512A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
CH870277A 1976-07-16 1977-07-13 CH622512A5 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/706,123 US4080454A (en) 1976-07-16 1976-07-16 5-M-Tolyloxyuracil, anti-ulcer agent

Publications (1)

Publication Number Publication Date
CH622512A5 true CH622512A5 (pl) 1981-04-15

Family

ID=24836300

Family Applications (1)

Application Number Title Priority Date Filing Date
CH870277A CH622512A5 (pl) 1976-07-16 1977-07-13

Country Status (29)

Country Link
US (1) US4080454A (pl)
JP (1) JPS5337673A (pl)
AR (1) AR213652A1 (pl)
AT (1) AT351561B (pl)
BE (1) BE856710A (pl)
CA (1) CA1061788A (pl)
CH (1) CH622512A5 (pl)
CS (1) CS212264B2 (pl)
DD (1) DD131556A5 (pl)
DE (1) DE2731736A1 (pl)
DK (1) DK139029B (pl)
EG (1) EG12762A (pl)
ES (1) ES460686A1 (pl)
FI (1) FI772183A7 (pl)
FR (1) FR2358399A1 (pl)
GB (1) GB1542178A (pl)
GR (1) GR68686B (pl)
HU (1) HU177713B (pl)
IL (1) IL52409A (pl)
LU (1) LU77764A1 (pl)
NL (1) NL7707729A (pl)
NO (1) NO772489L (pl)
PH (1) PH13190A (pl)
PL (1) PL103783B1 (pl)
PT (1) PT66808B (pl)
SE (1) SE421125B (pl)
SU (1) SU673169A3 (pl)
YU (1) YU171677A (pl)
ZA (1) ZA773927B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55158095A (en) * 1979-05-25 1980-12-09 Zenkosha Tokei Kk Controller for washing machine
EP1924262B1 (en) 2005-08-22 2011-11-16 Melior Pharmaceuticals I, Inc. Methods and formulations for modulating lyn kinase activity and treating related disorders
JP2010518860A (ja) * 2007-02-20 2010-06-03 メリオール・ファーマスーティカルズ・ワン・インコーポレイテッド Lynキナーゼの活性化剤の同定方法
CA2693809A1 (en) * 2007-07-23 2009-01-29 Melior Discovery, Inc. Methods of activating irs-1 and akt
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
US20130158055A1 (en) * 2010-05-28 2013-06-20 Andrew G. Reaume Prevention Of Pancreatic Beta Cell Degeneration
AU2018250795B2 (en) 2017-04-10 2022-02-10 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Treatment of adipocytes
US20210106581A1 (en) 2018-02-21 2021-04-15 Melior Pharmaceuticals I, Inc. Treatment Of Liver Diseases

Also Published As

Publication number Publication date
LU77764A1 (pl) 1978-02-02
DK139029B (da) 1978-12-04
AR213652A1 (es) 1979-02-28
EG12762A (en) 1979-12-31
CS212264B2 (en) 1982-03-26
FR2358399B1 (pl) 1980-10-17
FR2358399A1 (fr) 1978-02-10
JPS5512017B2 (pl) 1980-03-29
PT66808B (en) 1978-12-21
SU673169A3 (ru) 1979-07-05
IL52409A0 (en) 1977-08-31
AT351561B (de) 1979-08-10
PL103783B1 (pl) 1979-07-31
SE421125B (sv) 1981-11-30
ES460686A1 (es) 1978-12-01
CA1061788A (en) 1979-09-04
ZA773927B (en) 1978-05-30
GB1542178A (en) 1979-03-14
YU171677A (en) 1982-06-30
ATA509277A (de) 1979-01-15
SE7707471L (sv) 1978-01-17
FI772183A7 (pl) 1978-01-17
IL52409A (en) 1979-11-30
JPS5337673A (en) 1978-04-06
AU2663877A (en) 1978-05-18
NL7707729A (nl) 1978-01-18
DK139029C (pl) 1979-05-07
PH13190A (en) 1980-01-16
BE856710A (fr) 1978-01-11
PT66808A (en) 1977-08-01
GR68686B (pl) 1982-02-01
NO772489L (no) 1978-01-17
HU177713B (en) 1981-12-28
DD131556A5 (de) 1978-07-05
DK318177A (pl) 1978-01-17
PL199633A1 (pl) 1978-04-10
DE2731736A1 (de) 1978-01-26
US4080454A (en) 1978-03-21

Similar Documents

Publication Publication Date Title
EP1242069B1 (en) Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
JPH0326183B2 (pl)
CH641759A5 (fr) Phenethanolamines et composition pharmaceutique antineoplastique les contenant.
FR2527204A1 (fr) Nouveaux composes utiles comme medicaments anti-allergiques et procede et intermediaires pour leur separation
FR2532843A1 (fr) Composition pharmaceutique comprenant a titre de principe actif le phytol ou l'isophytol
LU81890A1 (fr) Nouvelles spiro-polycyclo-imidazolidinediones et compostion pharmaceutique les contenant
EP0024960B1 (fr) Nouvelles phénoxyamines hétérocycliques substituées, procédé pour leur préparation et leur application comme anesthésiques locaux
US4039589A (en) α-Substituted benzhydrol derivatives and a process for the preparation thereof
CA1070707A (en) 4-aroyl substituted phenoxy acetic acids and tetrazoles
US4080454A (en) 5-M-Tolyloxyuracil, anti-ulcer agent
CA1139763A (fr) Procede d'obtention de nouveaux aryltrifluoroethanols
US4473583A (en) Compositions containing certain derivatives of 4-phenyl-4-oxobuten-2-oic acid and methods of treatment using them
FR2493702A1 (fr) Compositions antivirales contenant des derives d'acide aminosulfonylhalogenobenzoique
CN113402414A (zh) 一种苯甲酸衍生物及其制法和药物用途
FR2742151A1 (fr) Utilisation de derives de bicycles mono ou dicetoniques, nouveaux composes obtenus et leur application en therapeutique
CH637650A5 (fr) Procede de preparation d'un acide chromone carboxylique.
FR2701261A1 (fr) Nouveaux composés glucuronides de la diosmétine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
CN107619428A (zh) 鸟氨酸与门冬氨酸二肽化合物的酰化衍生物及其应用
EP0395526B1 (fr) Nouveaux dérivés benzothiazolinoniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
LU85296A1 (fr) Procede de preparation de derives de pyrimidinetrione
CA1204770A (en) Fluorinated diaminoalkene derivatives
CH630618A5 (fr) Derives tetrazoles et leur preparation.
EP0390673A1 (fr) Nouveaux dérivés d'acyl-5 benzoxazolinone, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
CN101906069A (zh) (s)-2-取代-(3’-乙酰基-2’-吡啶酮-1’-基)乙酸及其制备方法和应用
BE889758A (fr) Oxazolidine-2,4-diones substituees en position 5 a action hypoglycemique

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased